Lin BioScience (ROCO:6696) FCF Margin % : 0.00% (As of Jun. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Lin BioScience FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Lin BioScience's Free Cash Flow for the six months ended in Jun. 2024 was NT$-578.34 Mil. Lin BioScience's Revenue for the six months ended in Jun. 2024 was NT$0.00 Mil. Therefore, Lin BioScience's FCF Margin % for the quarter that ended in Jun. 2024 was 0.00%.

As of today, Lin BioScience's current FCF Yield % is -11.44%.

The historical rank and industry rank for Lin BioScience's FCF Margin % or its related term are showing as below:

During the past 8 years, the highest FCF Margin % of Lin BioScience was -69338.95%. The lowest was -69338.95%. And the median was -69338.95%.

ROCO:6696's FCF Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -145.32
* Ranked among companies with meaningful FCF Margin % only.

Lin BioScience FCF Margin % Historical Data

The historical data trend for Lin BioScience's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lin BioScience FCF Margin % Chart

Lin BioScience Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

Lin BioScience Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
FCF Margin %	Get a 7-Day Free Trial											-	-	-	-	-

Competitive Comparison of Lin BioScience's FCF Margin %

For the Biotechnology subindustry, Lin BioScience's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lin BioScience's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lin BioScience's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Lin BioScience's FCF Margin % falls into.

Lin BioScience FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Lin BioScience's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-1014.783	/	0
	=	%

Lin BioScience's FCF Margin for the quarter that ended in Jun. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Jun. 2024 )	/	Revenue (Q: Jun. 2024 )
	=	-578.335	/	0
	=	%

Lin BioScience FCF Margin % Related Terms

Thank you for viewing the detailed overview of Lin BioScience's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Lin BioScience Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lin BioScience Inc (ROCO:6696) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Zhongxiao East Road, 12th Floor, No. 68, Section 5, Xinyi District, Taipei City, TWN, 110

Website

https://www.linbioscience.com

Lin BioScience Inc is a drug development company. It specializes in therapies for diseases with unmet medical needs. Its novel pipeline consists of first-in-class drugs aimed at treating life-threatening or disabling diseases in oncology, ophthalmology, cardiovascular, and metabolic disease.

Lin BioScience Headlines

No Headlines